Faaizah Arshad and Jessica Hagen speak with Josh Sackman, Cofounder and President of AppliedVR, on the immersive uses of a new produce RelieVRx for chronic lower back pain treatment and the steps to attaining FDA approval.<hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Faaizah Arshad and Jessica Hagen speak with Josh Sackman, Cofounder and President of AppliedVR, on the immersive uses of a new produce RelieVRx for chronic lower back pain treatment and the steps to attaining FDA approval. Hosted on Acast. See acast.com/privacy for more information.

Faaizah Arshad and Jessica Hagen speak with Josh Sackman, Cofounder and President of AppliedVR, on the immersive uses of a new produce RelieVRx for chronic lower back pain treatment and the steps to attaining FDA approval. Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Josh Sackman: Immersive Pain Treatment & FDA Approval

Our podcast explores how immersive technology is used in healthcare, focusing primarily on psychiatry. We speak to the companies and people behind medical XR experiences and professional researchers examining the use of this technology for patient care. We also discuss how treatment options will vary as the technology progresses and XR becomes more widely embraced by the healthcare community.&nbsp;Psychiatry XR's three hosts provide distinct perspectives of extended reality and the impact technology has on the healthcare ecosystem:&nbsp;Kim Bullock, M.D.&nbsp;is a practicing clinician in Behavioral Neurology, Neuropsychiatry, and Lifestyle Medicine. She is also a Clinical Professor in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine.&nbsp;She is the Founder and Director of Stanford's Neurobehavioral Clinic and Virtual Reality &amp; Immersive Technologies (VRIT) program and laboratory. She is also a leader and pioneer in telehealth services using XR. She's published numerous peer-reviewed articles and is a Cambridge and Oxford Press author about functional neurological disorders.&nbsp;&nbsp;She currently focuses on the use and dissemination of immersive technologies for telepsychiatry and its use in the augmentation of physiotherapy, psychotherapy, and skills acquisition. She treats a multitude of illness domains, including trauma, phobias, anxiety, pain, mood disorders, and somatic symptom-related disorders.&nbsp;&nbsp;Dr. Bullock also provides support and connects researchers, providers, and developers of immersive technology through the Stanford Psychiatry Immersive Technology Consortium (SPIT-C).&nbsp;Jessica Hagen is the Executive Editor of HIMSS Media outlet MobiHealthNews. Her current work focuses on the digital health sector, including transformation and innovation in the industry, investments, and partnerships. Her current and previous work includes covering the evolution of medical XR. She previously worked for the UK-based publication pharmaphorum, covering the pharmaceutical and biotechnology industries and general happenings within healthcare globally. She also reported on pharma’s use of medical XR, how immersive technology has progressed internationally, and what still needs to occur regarding developing widely accepted standards of evaluating virtual environments.&nbsp;Faaizah Arshad graduated from University of California, Los Angeles. She is interested in psychology, health equity, and leveraging technological innovations to improve patient outcomes.&nbsp;Thank you for choosing Psychiatry XR, and we hope you find each episode engaging and informative!<hr> Hosted on Acast. See <a style='color:grey;' target='_blank' rel='noopener noreferrer' href='https://acast.com/privacy'>acast.com/privacy</a> for more information.

Science

Health & Fitness

Technology

Our podcast explores how immersive technology is used in healthcare, focusing primarily on psychiatry. We speak to the companies and people behind medical XR experiences and professional researchers examining the use of this technology for patient care. We also discuss how treatment options will vary as the technology progresses and XR becomes more widely embraced by the healthcare community.   Psychiatry XR's three hosts provide distinct perspectives of extended reality and the impact technology has on the healthcare ecosystem:   Kim Bullock, M.D. is a practicing clinician in Behavioral Neurology, Neuropsychiatry, and Lifestyle Medicine. She is also a Clinical Professor in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine.   She is the Founder and Director of Stanford's Neurobehavioral Clinic and Virtual Reality & Immersive Technologies (VRIT) program and laboratory. She is also a leader and pioneer in telehealth services using XR. She's published numerous peer-reviewed articles and is a Cambridge and Oxford Press author about functional neurological disorders.    She currently focuses on the use and dissemination of immersive technologies for telepsychiatry and its use in the augmentation of physiotherapy, psychotherapy, and skills acquisition. She treats a multitude of illness domains, including trauma, phobias, anxiety, pain, mood disorders, and somatic symptom-related disorders.    Dr. Bullock also provides support and connects researchers, providers, and developers of immersive technology through the Stanford Psychiatry Immersive Technology Consortium (SPIT-C).   Jessica Hagen is the Executive Editor of HIMSS Media outlet MobiHealthNews. Her current work focuses on the digital health sector, including transformation and innovation in the industry, investments, and partnerships. Her current and previous work includes covering the evolution of medical XR. She previously worked for the UK-based publication pharmaphorum, covering the pharmaceutical and biotechnology industries and general happenings within healthcare globally. She also reported on pharma’s use of medical XR, how immersive technology has progressed internationally, and what still needs to occur regarding developing widely accepted standards of evaluating virtual environments.   Faaizah Arshad graduated from University of California, Los Angeles. She is interested in psychology, health equity, and leveraging technological innovations to improve patient outcomes.   Thank you for choosing Psychiatry XR, and we hope you find each episode engaging and informative! Hosted on Acast. See acast.com/privacy for more information.

Our podcast explores how immersive technology is used in healthcare, focusing primarily on psychiatry. We speak to the companies and people behind medical XR experiences and professional researchers examining the use of this technology for patient care. We also discuss how treatment options will vary as the technology progresses and XR becomes more widely embraced by the healthcare community.&nbsp;Psychiatry XR's three hosts provide distinct perspectives of extended reality and the impact technology has on the healthcare ecosystem:&nbsp;Kim Bullock, M.D.&nbsp;is a practicing clinician in Behavioral Neurology, Neuropsychiatry, and Lifestyle Medicine. She is also a Clinical Professor in the Department of Psychiatry and Behavioral Sciences at the Stanford University School of Medicine.&nbsp;She is the Founder and Director of Stanford's Neurobehavioral Clinic and Virtual Reality &amp; Immersive Technologies (VRIT) program and laboratory. She is also a leader and pioneer in telehealth services using XR. She's published numerous peer-reviewed articles and is a Cambridge and Oxford Press author about functional neurological disorders.&nbsp;&nbsp;She currently focuses on the use and dissemination of immersive technologies for telepsychiatry and its use in the augmentation of physiotherapy, psychotherapy, and skills acquisition. She treats a multitude of illness domains, including trauma, phobias, anxiety, pain, mood disorders, and somatic symptom-related disorders.&nbsp;&nbsp;Dr. Bullock also provides support and connects researchers, providers, and developers of immersive technology through the Stanford Psychiatry Immersive Technology Consortium (SPIT-C).&nbsp;Jessica Hagen is the Executive Editor of HIMSS Media outlet MobiHealthNews. Her current work focuses on the digital health sector, including transformation and innovation in the industry, investments, and partnerships. Her current and previous work includes covering the evolution of medical XR. She previously worked for the UK-based publication pharmaphorum, covering the pharmaceutical and biotechnology industries and general happenings within healthcare globally. She also reported on pharma’s use of medical XR, how immersive technology has progressed internationally, and what still needs to occur regarding developing widely accepted standards of evaluating virtual environments.&nbsp;Faaizah Arshad graduated from University of California, Los Angeles. She is interested in psychology, health equity, and leveraging technological innovations to improve patient outcomes.&nbsp;Thank you for choosing Psychiatry XR, and we hope you find each episode engaging and informative! Hosted on Acast. See <a href="https://acast.com/privacy" rel="noopener noreferrer">acast.com/privacy</a> for more information.

Share Josh Sackman: Immersive Pain Treatment & FDA Approval

Sign up to save your podcasts

Josh Sackman: Immersive Pain Treatment & FDA Approval

Josh Sackman: Immersive Pain Treatment & FDA Approval